December 12, 2017 Dr. Mansour Haeryfar and his team at Schulich Medicine & Dentistry have uncovered a new mechanism underlying the beneficial effects of PD-1-based “checkpoint inhibitor”, therapeutic agents that are approved for the treatment of several types of cancer and also under investigation in clinical trials for numerus other types.
September 06, 2016 From crafting a global definition of probiotics to developing novel therapies used by millions, Dr. Gregor Reid has significantly advanced our knowledge of how beneficial microbes, especially bacteria, contribute to health. Recognizing his role as a world leader in probiotics research, Dr. Reid has now been elected to the Fellowship of the Royal Society of Canada.
March 01, 2016 Eric Arts, one of the world’s leading HIV researchers, is developing vaccines to prevent new HIV-1 infections and vaccines to cure people already infected and living with HIV. To do so, Arts, who came from Case Western University, is using newly developed technologies related to genetic engineering, immune surveillance and next-generation sequencing.
November 09, 2015 Eric Arts, PhD, is leading Schulich Medicine & Dentistry’s contribution to the newly established European AIDS Vaccine Initiative (EAVI2020) — a C$33.2 million initiative that will bring together leading researchers from around the world to develop an effective HIV vaccine
December 12, 2017 Congratulations Graduating Honors Students:
- Jessica He for winning the Western Gold Medal for the Honors Specialization in Microbiology and Immunology
- Diliana Stratkova for winning the Gold Medal for the Honors Specialization in Biochemistry of Infection and Immunity
- Tayler Farrell for Winning the Kimberly Clarke Corporation Honors Thesis Award
January 12, 2015 Robert Murray, PhD, and his late wife Marion, are, and will forever be, part of the Department of Microbiology and Immunology. Their research, administrative and personal contributions have helped to create an outstanding culture of excellence within the Department and across Schulich School of Medicine & Dentistry
January 12, 2015 The first and only preventative HIV vaccine based on a genetically modified killed whole-virus has been making steady progress in Phase I Clinical Trials in the United States and the interim results are being analyzed in preparation for the next steps.
July 01, 2014 - Julia Tai for winning the Western Gold Medal for the Honors Specialization in Microbiology and Immunology
- Aaron Jonhson for winning the Gold Medal for the Honors Specialization in Biochemistry of Infection and Immunity and for Winning the Kimberly Clarke Corporation Honors Thesis Award
